Narrow-Band ultraviolet B phototherapy for the treatment of Iraqi patients with uremic pruritus
DOI:
https://doi.org/10.66344/jpad.30.3.2020.1482Keywords:
phototherapy uremic pruritusAbstract
Objective We aimed to assess the efficacy and safety of NB-UVB phototherapy in relieving uremic pruritus. Patients and Methods Over a period of 12 months, we recruited 17 patients with uremic pruritus having skin phototype III and more, aged from 21 to 67 years, 19(52.9%) females and 8(47.1%) male. They received NB-UVB, 2 sessions per week for 10 weeks. The response was assessed using 5-D itch scale. Results There was a 60.7±29.2% reduction of 5D-itch score compared to baseline   (19.53±3 versus 7.59±5.8, p<0.001). The mean cumulative dose of NB-UVB for one patient was 24.99 joule/ cm2 (1.25 ± 0.6 j/ cm2 per session). At the end of the trial, according to 5-D itch score criteria, 82.4% of patients were considered as a responder (good in 47.1%, very good in 35.3%) and after the treatment at follow up for 8 weeks, 35.7% developed pruritus again. Transient erythema was observed in 2 patients (10.5%) on phototherapy. Conclusion In our population, with Fitzpatrick s skin phototypes 3-5, NB-UVB phototherapy seems to be safe and effective choice for uremic pruritus, albeit tentative in some patients. High doses were required to achieve a satisfactory response.ÂReferences
- Mathur VS, Lindberg J, Germain M, Block G, Tumlin J, Smith M et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol 2010; 5:1410–1419.
- Dyachenko P, Shustak A, Rozenman D. Hemodialysis-related pruritus and associated cutaneous manifestations. Int J Dermatol 2006; 45:664–667.
- Yosipovitch G, Zucker I, Boner G, Gafter U, Shapira Y, David M. A questionnaire for the assessment of pruritus: validation in uremic patients. Acta Derm Venereol 2001; 81:108–111.
- Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis 2007; 5:11-20.
- Okada K, Matsumoto K. Effect of skincare with an emollient containing a high water content on mild uremic pruritus. Therap Apher Dialy 2004;8:419-422.
- Manenti L, Vaglio A, Costantino E, Danisi D, Oliva B, Pini S et al. Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation. J Nephrol 2005; 18:86-91.
-Gilchrest BA, Rowe JW, Brown RS, Steinman TI, Arndt KA. Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med. 1977;297:136–138.
-Gilchrest BA. Ultraviolet phototherapy of uremic pruritus. Int Dermatol. 1979;18:741–748.
-Tan JK, Haberman HF, Coldman AJ. Identifying effective treatments for uremic pruritus. J Am Acad Dermatol. 1991;25:811–818.
- Shintani Y, Yasuda Y, Kobayashi K, Maeda A, Morita A. Narrowband ultraviolet B radiation suppresses contact hypersensitivity. Photodermatol Photoimmunol Photomed. 2008; 24:32-37.
- Lugon JR. Uremic pruritus: a review. Hemodial Int 2005; 9:180-188.
- Szepietowski JC, Morita A, Tsuji T. Ultraviolet B induces mast cell apoptosis: a hypothetical mechanism of ultraviolet B treatment for uraemic pruritus. Medic hypoth 2002;58:167-170.
- Wallengren J, Sundler F. Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibers. Acta Derm Venereol 2004; 84:111-115.
- Ada S, Seçkin D, Budakoğlu İ, Özdemir FN. Treatment of uremic pruritus with narrowband ultraviolet B phototherapy: an open pilot study. J Am Acad Dermatol 2005; 53:149-151.
- Seckin D, Demircay Z, Akin O. Generalized pruritus treated with narrowband UVB. Inter J Dermatol 2007; 46:367-370.
- Wang TJ, Lan LC, Lu CS, Lin KC, Tung HH, Wu SF et al. Efficacy of narrowband ultraviolet phototherapy on renal pruritus. J Clin Nurs 2014; 23:1593-602.1
- Samson Yashar S, Gielczyk R, Scherschun L, Lim HW. Narrowband
ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses. Photodermatol Photoimmunol Photomed, 2003;19: 164-168.
- Ko MJ, Yang JY, Wu HY, Hu FC, Chen SI, et al. Narrowband ultraviolet B phototherapy for patients with refractory uremic pruritus: a randomized controlled trial. Br J Dermatol, 2011; 165: 633-639.
-Ibbotson SH, Bilsland D, Cox NH, Dawe RS, Diffy B, Edward C et al. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol 2004;151:283– 297.
- Lai JW, Chen HC, Chou CY, Yen HR, Li TC, SUN MF, et al. Transformation of 5-D itch scale and numerical rating scale in chronic hemodialysis patients. BMC Nephrol ,2017;18, 56 . DOI:10.1186/s12882-017-0475-z.
- Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010; 162:587- 593.
- Jin JO, Kwon HH, Choi MR, Youn JI. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy. Acta Dermatol Venereol 2011; 91:40-43.
- Dawe RS. A quantitative review of studies comparing the efficacy of narrowâ€band and broadâ€band ultraviolet B for psoriasis. Br J Dermatol 2003;149:669-672.
- Zanolli M. Phototherapy treatment of psoriasis today. J Am Acad Dermatol 2003; 49: S78–86.
- Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol 2008; 159:931– 935.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
